Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. - Wikidata - wikimedia - TriplyDB

Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.

Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.

http://www.wikidata.org/entity/Q37609985

about

Role of microRNAs in chemoresistance Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells Anti-Warburg effect of rosmarinic acid via miR-155 in gastric cancer cells.Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.The 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemia Radiation-induced microRNA-622 causes radioresistance in colorectal cancer cells by down-regulating Rb miR-663a regulates growth of colon cancer cells, after administration of antimicrobial peptides, by targeting CXCR4-p21 pathway.miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1.Global transcriptome and sequenome analysis of formalin-fixed salivary epithelial-myoepithelial carcinoma specimens miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2.MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma.Low miR-187 expression promotes resistance to chemoradiation therapy in vitro and correlates with treatment failure in patients with esophageal adenocarcinoma.Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients.Role of miR-647 in human gastric cancer suppression Investigation on tissue specific effects of pro-apoptotic micro RNAs revealed miR-147b as a potential biomarker in ovarian cancer prognosis.Biological effects and clinical characteristics of microRNA-106a in human colorectal cancer.Visual detection of glial cell line-derived neurotrophic factor based on a molecular translator and isothermal strand-displacement polymerization reaction.MicroRNA-647 Targets SRF-MYH9 Axis to Suppress Invasion and Metastasis of Gastric Cancer.Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients.Ancient and modern: hints of a core post-transcriptional network driving chemotherapy resistance in ovarian cancer.Regulation of drug resistance and metastasis of gastric cancer cells via the microRNA647-ANK2 axis.MicroRNA-432 targeting E2F3 and P55PIK inhibits myogenesis through PI3K/AKT/mTOR signaling pathway.Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer.MiRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation.Involvement of non-coding RNAs in chemotherapy resistance of ovarian cancer.Tumor promoter role of miR‑647 in gastric cancer via repression of TP73

P2860

Q26770485-4D1CAABE-ED16-4D8D-BD40-1143A85B2D57 Q34155182-2AB212F4-FAF7-421A-8182-9A99E01E0F13 Q35538822-0C63D736-993C-40DD-AB12-AE373B9C7AB6 Q35653619-69336297-0A11-42A2-A71D-9A3FB18D3E91 Q35781447-66E4F2B4-0281-443D-9FFE-1E20AA3BDE6C Q35853830-9DE5E1F1-DE02-4C68-9817-4B91FFDDF5A3 Q36140693-F37C447D-97A3-4D0E-941D-CA3BF886CCE0 Q36243109-30850A51-7878-4481-9842-2E11D94D230D Q36726137-2668B7BC-FDEC-4DDE-9606-059955E7BD8B Q36838327-2BF7CCC5-1382-455F-87C8-16EE1A67258E Q36954415-0B57B6E0-D542-4D2F-9169-3C14FFCA8FB9 Q37190245-73FAE462-72C3-48B1-A4F4-7E6F51FB3DE7 Q37353927-38E5DEA1-7A40-4B0D-BA84-CF3776DCCE39 Q37641610-375A5505-F9B4-4CD2-8DF1-C5A50C1162CD Q37672829-1963A511-28FE-473C-BB5A-3664F25BA1B8 Q37720083-5F74F698-C0AD-444D-9C76-AF358F0138CD Q37745830-784B852C-B1F0-4E79-8E9F-762AFCB5B1D9 Q38686015-41EB2FA8-1732-451B-AA9E-E30DEDC902F6 Q38890210-D68CC3C9-1DF0-4529-8A74-273ED8F80B4F Q41239424-9F6D89C3-76E2-479B-B121-DCE388147282 Q42122998-538DD5BF-3917-42E9-A299-25A61F1595F2 Q47200415-7AD995E0-4BE5-47E9-A60C-732D29C9A5D2 Q50067842-FEFCC0EA-3238-4090-BB09-1CF6E0A7B01E Q50161677-F9F107B7-8D03-4EBB-9E1F-44ACFE8771CB Q54923469-54629C19-1907-4FA0-834D-DDF6B9420DBC Q54977715-F0D74AD7-9ECC-4359-ABB4-70CB84082FB0 Q55038905-A4E20DEF-D26C-4179-98B9-138F9125F260 Q58798403-325D488F-92F5-4FBC-8B42-2A86FE3FAD3D

P2860

Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells.

http://www.wikidata.org/entity/Q37609985

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Differential microRNA expressi ...... tance in ovarian cancer cells.

@en

Differential microRNA expressi ...... tance in ovarian cancer cells.

@nl

type

label

Differential microRNA expressi ...... tance in ovarian cancer cells.

@en

Differential microRNA expressi ...... tance in ovarian cancer cells.

@nl

prefLabel

Differential microRNA expressi ...... tance in ovarian cancer cells.

@en

Differential microRNA expressi ...... tance in ovarian cancer cells.

@nl

P1433

Q37609985-95167F3E-9447-4CBA-B38C-2C9C4C805ABF

P1476

Q37609985-CD412572-CDC9-42A0-BE78-6FC3BADE8331

P2093

Q37609985-0EB6B68F-045F-468D-8C31-287EAE1000FC

Q37609985-3218721F-FECB-457B-BB1A-B169464BD628

Q37609985-8C33B5D5-41C8-4E4F-BAC9-12EEF92A53A9

Q37609985-C4A10658-037E-4FFD-B33D-142DCFBBD172

Q37609985-EB0193FC-3002-4A51-BD0F-415156CED80A

Q37609985-ECA2FA31-DD56-444F-A275-4C83E0712ED3

Q37609985-F164C801-9895-4ED3-8408-ED07006D642A

P2860

Q37609985-0901116A-776D-4C8F-A4E6-DFAE1A85B617

Q37609985-109CC2E4-B638-4B0E-8B45-1C5B906AB7F3

Q37609985-116690F4-EA02-4AC2-B8F8-4B33AE8A622C

Q37609985-18852955-DF8C-4E92-98FD-FB2CD4082190

Q37609985-18A0F8BA-E756-444C-9D6D-CE595407E605

Q37609985-193EE403-3493-4A6D-BD85-61DB50EF3961

Q37609985-1D35FB8D-11C7-4E59-B05E-9AEAE425D5DF

Q37609985-21043ADA-5F0E-4B2F-ACB3-DD746263FAA9

Q37609985-22E8DDA3-86F4-484D-AC72-8D4829DFCB31

Q37609985-23217866-1956-4AC8-9368-F35E38F7FDFF

P304

Q37609985-6A7E1BC9-7687-44A0-8A8F-7A712B941F67

P31

Q37609985-415CE375-7865-4438-9C0A-6E05A237C752

P356

Q37609985-322A7323-B864-463D-A26B-2032974DD14B

P407

Q37609985-A5FE34C3-AB91-4C40-A729-F7E80669CEC9

P478

Q37609985-087ADBF7-36CE-4B77-8132-3037C23AD395

P577

Q37609985-F7B8CA5E-237F-44AF-92FC-085A03A5E67F

P698

Q37609985-AB51945F-1E62-4687-B9CD-13B74F2D64CE

P921

Q37609985-37FB8107-BC68-4118-91E7-9330A9DCF58A

Q37609985-EEA88A8E-6016-4930-9601-66E83F99775E

P932

Q37609985-CADDF2CB-BDBC-45DD-9797-50717A23633C

P356

P1433

Drug Design, Development and Therapy

P1476

Differential microRNA expressi ...... tance in ovarian cancer cells.

@en

P2093

Doin Jeon

http://www.w3.org/2001/XMLSchema#string

Eun Young Kim

http://www.w3.org/2001/XMLSchema#string

Helena Suhyun Kim

http://www.w3.org/2001/XMLSchema#string

Jin Woo Choi

http://www.w3.org/2001/XMLSchema#string

Juinn-Lin Liu

http://www.w3.org/2001/XMLSchema#string

Woong Shick Ahn

http://www.w3.org/2001/XMLSchema#string

Yong-Wan Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Identifying microRNA/mRNA dysregulations in ovarian cancer

Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

miRBase: tools for microRNA genomics

Myosin II co-chaperone general cell UNC-45 overexpression is associated with ovarian cancer, rapid proliferation, and motility

Integrated genomic analyses of ovarian carcinoma

MicroRNA signatures in human cancers

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

Synergistic anti-tumor effects of combination of photodynamic therapy and arsenic compound in cervical cancer cells: in vivo and in vitro studies

Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma

P304

293-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S51969

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24591819

http://www.w3.org/2001/XMLSchema#string

P921

microRNA expression

P932

3938445

http://www.w3.org/2001/XMLSchema#string